2020
DOI: 10.1177/0194599820922992
|View full text |Cite
|
Sign up to set email alerts
|

COVID‐19 Anosmia Reporting Tool: Initial Findings

Abstract: There is accumulating anecdotal evidence that anosmia and dysgeusia are associated with the COVID-19 pandemic. To investigate their relationship to SARS-CoV2 infection, the American Academy of Otolaryngology–Head and Neck Surgery developed the COVID-19 Anosmia Reporting Tool for Clinicians for the basis of this pilot study. This tool allows health care providers to confidentially submit cases of anosmia and dysgeusia related to COVID-19. We analyzed the first 237 entries, which revealed that anosmia w… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

25
383
4
23

Year Published

2020
2020
2022
2022

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 343 publications
(452 citation statements)
references
References 8 publications
25
383
4
23
Order By: Relevance
“…Moreover, our study group recently showed, that anosmia was present in 86% in a series of 417 patients with mild-to-moderate COVID-19 disease, and appeared before other symptoms in 11.8% [5]. In the same way, Kaye et al described in a series of 237 patients that anosmia was noted in 73% of subjects prior to COVID-19 diagnosis and was the initial symptom in 26.6% [11]. In a larger series of 1,420 mild to moderate COVID+ patients, our Bayesian analysis identified that reported anosmia was a key symptom in COVID-19 infection with 70.2% of cases (Lechien et al, submitted).…”
Section: Discussionsupporting
confidence: 68%
“…Moreover, our study group recently showed, that anosmia was present in 86% in a series of 417 patients with mild-to-moderate COVID-19 disease, and appeared before other symptoms in 11.8% [5]. In the same way, Kaye et al described in a series of 237 patients that anosmia was noted in 73% of subjects prior to COVID-19 diagnosis and was the initial symptom in 26.6% [11]. In a larger series of 1,420 mild to moderate COVID+ patients, our Bayesian analysis identified that reported anosmia was a key symptom in COVID-19 infection with 70.2% of cases (Lechien et al, submitted).…”
Section: Discussionsupporting
confidence: 68%
“…Lechien et al [9] are the first peer-reviewed multicentre study, reporting on a series of 417 confirmed mildmoderate patients; 85.6 and 88.0% reported olfactory and gustatory dysfunction, respectively, with olfactory dysfunction emerging before other symptoms in 11.8% cases. Kaye et al report on 237 US patients with COVID-19 and found that 73% reported anosmia, and that loss of sense of smell was the initial symptom in 26.6% [10].…”
Section: Discussionmentioning
confidence: 99%
“…Post-viral odor loss has been identi ed in many viral diseases, primarily In uenza and Rhinoviruses [12][13][14]. Patients with sudden olfactory loss were even reported in the MERS-CoV outbreak in 2012 [25]. In the COVID -19 pandemic, which started in China on December 2019, patients with sudden olfactory loss have been reported in countries such as China, Italy, Spain, Singapor and USA where pandemics are frequently seen.…”
Section: Discussionmentioning
confidence: 99%